A plastic surgeon with a popular YouTube channel just put numbers to a fear most people carry quietly: some cancers are far deadlier than others, and the gap is brutal.
Quick Take
- Dr. Michael Gartner, a board-certified surgeon, reacted to a ranking of the five worst cancers in a video that drew roughly 59,000 views.
- Federal cancer data backs up the grim picture, showing pancreatic cancer and glioblastoma brain cancer among the lowest five-year survival rates in the country.
- Pancreatic cancer survival sits near 13.7 percent, while glioblastoma survival is even lower, around 6.6 percent.
- Experts caution that no single “worst cancer” list can capture every patient’s situation, since survival rates vary by stage and subtype.
Why This Ranking Struck A Nerve
Cancer rankings get clicks because they turn an abstract fear into a concrete list. Gartner’s video followed that format, reacting to claims about which cancers carry the grimmest odds. The video’s popularity shows how hungry people are for straight talk from a real doctor, not just headlines, when it comes to understanding what makes certain cancers so hard to beat.
The two cancers that consistently top these grim lists are pancreatic cancer and glioblastoma, an aggressive brain tumor. Government cancer researchers tracked outcomes between 2016 and 2022 and found pancreatic cancer’s overall five-year survival rate at 13.7 percent. Glioblastoma came in even lower, at just 6.6 percent. Those numbers explain why both cancers show up near the top of nearly every “deadliest” list doctors and researchers publish.
What Makes These Cancers So Hard To Catch And Treat
Pancreatic cancer hides well. The pancreas sits deep in the abdomen, and early symptoms are vague or absent, so most patients are diagnosed only after the disease has already spread. The National Cancer Institute reports that just 13 out of 100 people diagnosed at any stage survive five years, a number that drops sharply once the cancer reaches distant organs.
Glioblastoma poses a different problem. It grows fast and tangles itself into healthy brain tissue, making full surgical removal nearly impossible without damaging critical function. Standard treatment combines surgery, radiation, and chemotherapy drugs like temozolomide, but even aggressive care rarely stops the tumor for long. Researchers at the Salk Institute have called it one of the five deadliest cancers for exactly this reason, noting survival rates that barely clear single digits in many studies.
Why One List Can Never Tell The Whole Story
Doctors who study cancer survival data stress a simple point: a “worst cancer” list measures averages, not individuals. The Mayo Clinic explains that survival statistics describe how large groups of patients with the same cancer and stage fared, but they cannot predict what will happen to any one person sitting in an exam room. A patient caught early, with access to a top surgical team, can beat the odds that define an entire category.
Cancer staging matters just as much as cancer type. The American Cancer Society notes that a five-year survival rate tied to a specific stage changes dramatically depending on whether the disease was found early or late. That is why serious oncologists resist flattening dozens of cancer subtypes into one ranked list, even when the ranking contains real, sobering data.
The Bigger Picture For Patients And Families
None of this diminishes why these rankings resonate. Fear over pancreatic cancer and glioblastoma is earned, backed by federal survival statistics that have barely budged in years despite research spending. What matters for everyday Americans is less the ranking itself and more the takeaway: early detection and fast access to specialists remain the strongest tools against the deadliest cancers, regardless of where they land on anyone’s top five.
Content like Gartner’s video serves a purpose precisely because it comes from a licensed physician reacting with clinical context, rather than an anonymous internet claim. Readers deserve that kind of grounded, credentialed commentary on health topics that genuinely scare them, especially when the underlying statistics are as serious as these.
The lesson from the data is straightforward. Some cancers remain brutally difficult to catch early and treat effectively, and pancreatic cancer and glioblastoma sit at the top of that painful list for good reason.
Sources:
cancerprogressreport.aacr.org, cancer.org, cancer.gov, salk.edu, tubeai.app, nature.com, mayoclinic.org
